Gut microbiome and cardiovascular disease. (May 2020)

• Record Type: Journal Article
• Authors: Zhao, Yongzhong; Wang, Zeneng
• Is Part Of: Current opinion in cardiology. Volume 35:Number 3(2020:May)
• Publication Date: 2020-05
• Subjects: cardiovascular disease -- drug efficacy -- gut microbiome -- microbial metabolites -- physical exercise; Cardiology -- Periodicals; Cardiology -- Periodicals; Heart Diseases -- Periodicals; Cardiology; Periodicals; 616.12
• DOI: 10.1097/HCO.0000000000000720
• Languages: English
• ISSNs: 0268-4705

Abstract

Abstract : Purpose of review: This review aims to highlight the association between gut microbiome and cardiovascular disease (CVD) with emphasis on the possible molecular mechanisms by which how gut microbiome contributes to CVD. Recent findings: Increasingly, the roles of gut microbiome in cardiovascular health and disease have gained much attention. Most of the investigations focus on how the gut dysbiosis contributes to CVD risk factors and which gut microbial-derived metabolites mediate such effects. Summary: In this review, we discuss the molecular mechanisms of gut microbiome contributing to CVD, which include gut microbes translocalization to aortic artery because of gut barrier defect to initiate inflammation and microbial-derived metabolites inducing inflammation-signaling pathway and renal insufficiency. Specifically, we categorize beneficial and deleterious microbial-derived metabolites in cardiovascular health. We also summarize recent findings in the gut microbiome modulation of drug efficacy in treatment of CVD and the microbiome mechanisms by which how physical exercise ameliorates cardiovascular health. Gut microbiome has become an essential component of cardiovascular research and a crucial consideration factor in cardiovascular health and disease.